A 1.5 hour webinar delivered by world-leading experts providing an overview of the following topics: 12 things to get right when implementing a vaccination program Addressing myths and misunderstandings regarding vaccinations with a focus on RIDs (interactive) Key learnings from the recent pandemics Future pandemic preparedness The webinar includes an interactive Q&A session with the experts
At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized.
To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing in parallel our own state-of-the-art manufacturing processes to complement our drug development platforms.
